ENST00000373827.6:c.96+96132C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000373827.6(ANK3):​c.96+96132C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.209 in 152,042 control chromosomes in the GnomAD database, including 3,607 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.21 ( 3607 hom., cov: 32)

Consequence

ANK3
ENST00000373827.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.00400

Publications

6 publications found
Variant links:
Genes affected
ANK3 (HGNC:494): (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011]
ANK3 Gene-Disease associations (from GenCC):
  • intellectual disability-hypotonia-spasticity-sleep disorder syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • intellectual disability
    Inheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.335 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000373827.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
NM_001204404.2
c.63+53411C>T
intron
N/ANP_001191333.1
ANK3
NM_001204403.2
c.96+96132C>T
intron
N/ANP_001191332.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ANK3
ENST00000373827.6
TSL:1
c.96+96132C>T
intron
N/AENSP00000362933.2
ANK3
ENST00000503366.6
TSL:2
c.63+53411C>T
intron
N/AENSP00000425236.1
ANK3
ENST00000510382.1
TSL:2
n.102-10429C>T
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.209
AC:
31815
AN:
151924
Hom.:
3602
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.184
Gnomad AMI
AF:
0.169
Gnomad AMR
AF:
0.275
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.340
Gnomad SAS
AF:
0.351
Gnomad FIN
AF:
0.275
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.182
Gnomad OTH
AF:
0.191
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.209
AC:
31844
AN:
152042
Hom.:
3607
Cov.:
32
AF XY:
0.219
AC XY:
16267
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.184
AC:
7654
AN:
41506
American (AMR)
AF:
0.276
AC:
4220
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
637
AN:
3468
East Asian (EAS)
AF:
0.340
AC:
1744
AN:
5134
South Asian (SAS)
AF:
0.349
AC:
1680
AN:
4810
European-Finnish (FIN)
AF:
0.275
AC:
2906
AN:
10578
Middle Eastern (MID)
AF:
0.160
AC:
47
AN:
294
European-Non Finnish (NFE)
AF:
0.182
AC:
12398
AN:
67972
Other (OTH)
AF:
0.192
AC:
404
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1297
2594
3892
5189
6486
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
358
716
1074
1432
1790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.194
Hom.:
5175
Bravo
AF:
0.210
Asia WGS
AF:
0.347
AC:
1205
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.78
DANN
Benign
0.36
PhyloP100
0.0040
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2153522; hg19: chr10-62278812; API